Time‐dependent benefits of pre‐treatment with new oral P2Y12‐inhibitors in patients addressed to primary PCI for acute ST‐elevation myocardial infarction
暂无分享,去创建一个
F. Bartolomucci | E. Navarese | C. Forleo | V. Paradies | S. Favale | F. Addabbo | A. Bortone | M. Pepe | F. Bianchi | N. Signore | G. Contegiacomo | Ottavio Di Cillo | F. P. Bianchi | D. Zanna | A. Cafaro